7 March, 2018
NIA was pleased to host its quarterly open webinar dedicated this March to nanomedicine. "Nanomedicine – Diagnostics and therapeutics advancing through nanotechnology" showcased two NIA Members, Endomag and Senolytic and followed up with a whirlwind tour of the global device and therapeutics regulatory framework.
Delegates joined from Europe, the US and Asia and NIA is pleased to share slides from the meeting, with a recorded version available for Members.
Slides are available here:
- Welcome and introduction to nanotechnology and its potential within healthcare. Claire Skentelbery, NIA
- Endomag Case study. Eric Mayes, CEO
- Senolytic case study. Marc Ramis Castelltort, CEO
- Global Regulatory Framework for devices and drugs. Guillaume Flament, NIA
NIA thanks all its speakers for their work in preparing presentations and we look forward to future support for nanomedicines development.
